Cytodyn Inc (CYDY)

[finesand]

The issue I see would be too much greed on behalf of CYDY

The Warrant neutral (in the money for cash, not affecting buyout price)
$1/sh would be around $400M and hence a $1.50 - $2.00 ($600M - $800M)
would be doable without too much fuss to explain this to buyers SH
knowing cancer is added super early stage bonus.

I hear longs already: Too cheap,
but heck - the patients would finally benefit as the pipeline could get pushed forward.

$1.50 also the lowered PT from the 'old friends' (They were at $2 - $2.50 months/years ago).

But enough positive speculation, let's see what NP can deliver for his redemption.